Markt für Gabapentin-Enacarbil - Erkenntnisse aus globaler und regionaler Analyse - Prognose bis 2031

  • Report Code : TIPRE00018109
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

MARKTEINFÜHRUNG Gabapentin Enacarbil ist ein Analgetikum und Antikonvulsivum aus der Klasse der Gabapentinoide und ein Prodrug von Gabapentin. Dieses Medikament wird zur Behandlung des mittelschweren bis schweren Restless-Legs-Syndroms eingesetzt. Es wird auch zur Linderung von Nervenschmerzen nach Gürtelrose (einem schmerzhaften Ausschlag aufgrund einer Herpes-Zoster-Infektion) angewendet. MARKDTYNAMIK Zu den Faktoren, die zum Wachstum des Gabapentin-Enacarbil-Marktes beitragen, gehören die hohe Prävalenz neurologischer Erkrankungen in der Bevölkerung und die zunehmende Forschung und Entwicklung im Bereich Analgetika. Allerdings können die Nebenwirkungen des Arzneimittels Schwindel, Schläfrigkeit und Ataxie das Marktwachstum bremsen. MARKTUMFANG Die „Gabapentin Enacarbil-Marktanalyse bis 2031“ ist eine spezialisierte und eingehende Studie der Pharmaindustrie mit besonderem Schwerpunkt auf der globalen Markttrendanalyse. Der Bericht soll einen Überblick über den Gabapentin-Enacarbil-Markt mit detaillierter Marktsegmentierung nach Typ und Anwendung geben. Für den Gabapentin-Enacarbil-Markt wird im Prognosezeitraum ein hohes Wachstum erwartet. Der Bericht enthält wichtige Statistiken zum Marktstatus der führenden Akteure auf dem Gabapentin-Enacarbil-Markt und bietet wichtige Trends und Chancen auf dem Markt. MARKTSEGMENTIERUNG Der Gabapentin-Enacarbil-Markt ist nach Typ und Anwendung segmentiert. Je nach Typ wird der Gabapentin-Enacarbil-Markt in Kapseln und Tabletten unterteilt. Je nach Anwendung kann der Gabapentin-Enacarbil-Markt in postherpetische Neuralgie (phn), Restless-Legs-Syndrom (rls) und andere unterteilt werden. Der Bericht bietet einen detaillierten Überblick über die Branche, einschließlich qualitativer und quantitativer Informationen. Es bietet einen Überblick und eine Prognose des Gabapentin-Enacarbil-Marktes basierend auf verschiedenen Segmenten. Es bietet auch Marktgrößen- und Prognoseschätzungen für die Jahre 2021 bis 2031 in Bezug auf fünf Hauptregionen, nämlich: Nordamerika, Europa, Asien-Pazifik (APAC), Naher Osten und Afrika (MEA) sowie Süd- und Mittelamerika. Der Gabapentin-Enacarbil-Markt nach Regionen wird später nach jeweiligen Ländern und Segmenten unterteilt. Der Bericht umfasst Analysen und Prognosen für 18 Länder weltweit sowie aktuelle Trends und Chancen in der Region. Der Bericht analysiert Faktoren, die den Gabapentin-Enacarbil-Markt sowohl auf der Nachfrage- als auch auf der Angebotsseite beeinflussen, und bewertet weiter die Marktdynamik, die den Markt im Prognosezeitraum beeinflusst, d. h. Treiber, Beschränkungen, Chancen und zukünftige Trends. Der Bericht bietet außerdem eine umfassende Schädlingsanalyse für alle fünf Regionen, nämlich: Nordamerika, Europa, APAC, MEA sowie Süd- und Mittelamerika nach Bewertung politischer, wirtschaftlicher, sozialer und technologischer Faktoren, die den Gabapentin-Enacarbil-Markt in diesen Regionen beeinflussen. MARKTSPIELER Der Bericht behandelt wichtige Entwicklungen auf dem Gabapentin-Enacarbil-Markt als organische und anorganische Wachstumsstrategien. Verschiedene Unternehmen konzentrieren sich auf organische Wachstumsstrategien wie Produkteinführungen, Produktzulassungen und andere wie Patente und Veranstaltungen. Zu den auf dem Markt beobachteten anorganischen Wachstumsstrategien gehörten Akquisitionen sowie Partnerschaften und Kooperationen. Diese Aktivitäten haben den Weg für die Erweiterung des Geschäfts und des Kundenstamms der Marktteilnehmer geebnet. Aufgrund der steigenden Nachfrage nach Gabapentin-Enacarbil auf dem Weltmarkt werden den Marktteilnehmern auf dem Gabapentin-Enacarbil-Markt in Zukunft voraussichtlich lukrative Wachstumschancen geboten. Nachfolgend finden Sie eine Liste einiger Unternehmen, die auf dem Gabapentin-Enacarbil-Markt tätig sind. Der Bericht enthält auch die Profile der wichtigsten Akteure auf dem Gabapentin-Enacarbil-Markt sowie deren SWOT-Analyse und Marktstrategien. Darüber hinaus konzentriert sich der Bericht auf führende Branchenakteure mit Informationen wie Firmenprofilen, angebotenen Komponenten und Dienstleistungen, Finanzinformationen der letzten drei Jahre und wichtigen Entwicklungen in den letzten fünf Jahren.
    • GlaxoSmithKline plc • Sun Pharmaceutical Industries Ltd. • Novartis AG • Pfizer Inc. • Glenmark Pharmaceuticals Limited • Astellas Pharma Inc. • AstraZeneca plc • Aurobindo Pharma . • Takeda Pharmaceutical Company Limited • Intas Pharmaceuticals Ltd.
Das engagierte Forschungs- und Analyseteam des Insight Partners besteht aus erfahrenen Fachleuten mit fortgeschrittenem statistischem Fachwissen und bietet verschiedene Anpassungsoptionen in der bestehenden Studie.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Gabapentin Enacarbil Market?

Gabapentin Enacarbil Market is expected to grow at a CAGR of 5.2% between 2023-2031

What are the driving factors impacting the Gabapentin Enacarbil Market?

The primary drivers for the Gabapentin Enacarbil market are the increasing prevalence of neurological disorders such as epilepsy, neuropathic pain, and restless leg syndrome. The aging population, combined with growing awareness of these conditions, is driving demand for effective treatments. Further research and development activities focused on new applications and formulations of gabapentin enacarbil will also contribute to the growth of the market.

What are the future trends of the Gabapentin Enacarbil Market?

There is significant promise in the Gabapentin Enacarbil market, as the trends emerging are multifarious. Innovative formulations and delivery systems that improve patient compliance and, thus, treatment efficacy are crucial developments in this field. More studies on gabapentin enacarbil are being conducted, opening doors to new applications of this medication for neurological disorders such as migraine and fibromyalgia. This will further increase the emphasis on personalized medicine and pharmacogenomics, which may lead to more targeted and effective use of gabapentin enacarbil, optimizing treatment outcomes for individual patients.

Which are the leading players operating in the Gabapentin Enacarbil Market?

The leading players of the market are: GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Novartis AG Pfizer Inc., Glenmark Pharmaceuticals Limited, Astellas Pharma Inc., AstraZeneca plc, Aurobindo Pharma., Takeda Pharmaceutical Company Limited, Intas Pharmaceuticals Ltd.

What are the deliverable formats of the Gabapentin Enacarbil Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. GlaxoSmithKline plc
2. Sun Pharmaceutical Industries Ltd.
3. Novartis AG
4. Pfizer Inc.
5. Glenmark Pharmaceuticals Limited
6. Astellas Pharma Inc.
7. AstraZeneca plc
8. Aurobindo Pharma.
9. Takeda Pharmaceutical Company Limited
10. Intas Pharmaceuticals Ltd.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.